| Schedule of Earnings Per Share, Basic and Diluted |
The reconciliation of the numerator and denominator of basic and diluted earnings per share was as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended June 30, | | Six months ended June 30, | | (in millions of U.S. dollars except share and per share amounts ) | | 2025 | | 2024 | | 2025 | | 2024 | | Numerator: | | | | | | | | | | Net income attributable to equity holders of Constellium | | 36 | | 76 | | 73 | | 97 | | Denominator: | | | | | | | | | | Basic - weighted-average ordinary shares outstanding | | 140,820,828 | | 146,271,938 | | 141,665,123 | | 146,534,099 | | Dilutive effect of non-vested restricted stock units and performance-based restricted stock units | | 1,423,571 | | 2,960,935 | | 1,508,801 | | 3,187,852 | | Diluted - weighted-average ordinary shares, of restricted stock units and performance-based restricted stock units | | 142,244,399 | | 149,232,873 | | 143,173,924 | | 149,721,951 | | Basic earnings per share | | $ | 0.25 | | $ | 0.52 | | $ | 0.51 | | $ | 0.66 | | Diluted earnings per share | | $ | 0.25 | | $ | 0.51 | | $ | 0.51 | | $ | 0.65 |
For the three and six months ended June 30, 2025, and 2024, no ordinary shares assuming exercise of equity-based awards were excluded from the computation of diluted earnings per share because the effect of their exercise would be anti-dilutive.
|